Transire Bio in top 15 of De Vigier Award
Transire Bio is selected in the top 15 of W.A. De Vigier Award! The next selection stage will involve evaluating business plans by the foundation’s experts and the new round of pitching to the foundation’s board in April.
Read the full press release at https://devigier.ch/press-release-top-15-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.
Transire Bio in top 50 of De Vigier Award
We are honored to have given our first official pitch with Transire Bio at the top 50 of W.A. De Vigier Award. We were selected among 310 applicants and we will have a chance to pitch in Soloturn in the Life Sciences & Biotech & Pharma cluster.
Read the press release at https://devigier.ch/press-release-selection-day-top50-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.
Transire Bio at SPARK Night Zurich
Transire Bio was selected to participate at SPARK Night Zurich. Our co-founders David and Nevena presented our technology and discussed open questions with the selected group of experts, investors and fellow entrepreneurs. SPARK Zurich provides a mentoring network for researchers with biotech projects. It is based on the SPARK program developed at Stanford University, which substantially increases the translational success rate of the ideas coming from academia.
Learn more about the Spark Night Zurich at https://www.sparkzurich.ch/.